Skip to main content
Home

Main navigation

  • Home
  • News
  • About HIV
  • About us
  • Donate
Search
Donate now

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you.

I am a UK taxpayer and I understand that if I pay less Income and /or Capital Gains Tax than the amount of Gift Aid claimed on all my donations in the relevant tax year, it is my responsibility to pay any difference.

In our 35th year we’re asking people to donate £35 – that’s just £1 for every year we’ve been providing life-changing information. Any donation you make helps us continue our work towards a world where HIV is no longer a threat to health or happiness.

  • £5 allows us to reach millions of people globally with accurate and reliable resources about HIV prevention and treatment.
  • £10 helps us produce news and bulletins on the latest developments in HIV for healthcare staff around the world.
  • £35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts.
Conferences

EACS 2011

The 13th European AIDS Conference took place in Belgrade in October 2011.
Treatment outcomes & life expectancy

'High viral load' should mean over half a million copies, not over 100,000, Rome study suggests

24 October 2011
Cancer

Lung cancer is biggest killer in study of non-AIDS-defining cancers

22 October 2011
Treatment guidelines

New European HIV treatment guidelines expand treatment recommendations but anticipate possible drug shortages

18 October 2011
Treatment guidelines

US panel updates antiretroviral treatment guidelines

18 October 2011
New & experimental HIV treatments

Switching from efavirenz to rilpivirine single tablet is safe and effective

18 October 2011
Hepatitis C treatment

People on methadone can succeed on hepatitis C treatment

18 October 2011
Hepatitis C treatment

Gene variant that helps hepatitis C treatment may hinder HIV treatment

14 October 2011
HIV testing policies & guidelines

Testing people with conditions suggesting HIV could pick up more recent infections, Europe-wide study finds

14 October 2011
New & experimental HIV treatments

Raltegravir continues to perform well at four years

14 October 2011
New & experimental HIV treatments

Dolutegravir is potent but twice-daily works better for integrase-resistant

14 October 2011
Neurological & cognitive problems

How common is neurocognitive impairment in people with HIV? It depends who you compare them with

13 October 2011
Sign up for our email bulletins.
Sign up

Editors’ picks from other sources

Health services & systems

Treatment Costs Higher When HIV Diagnosis Is Delayed

Patients presenting late with HIV incur significantly higher healthcare costs, Maria Martinez-Colubi, MD, from the Ramón y Cajal Hospital in Madrid, Spain, told delegates here at the 13th European AIDS Conference of the European AIDS Clinical Society (EACS).
Medscape (free registration required)
1 Nov 11
Hepatitis C treatment

EACS: Predictors of HCV Viral Load in HIV/HCV Coinfected Patients

Hepatitis C virus (HCV) RNA levels rise over time in HIV/HCV coinfected people, reducing the chances of sustained response to interferon-based treatment. But antiretroviral therapy may help control HCV viral load and contribute to higher likelihood of treatment success, according to a report presented at the 13th European AIDS Conference (EACS 2011) this month in Belgrade.
HIVandhepatitis.com
27 Oct 11
Hepatitis C treatment

EACS: Antiretroviral Therapy Reduces Liver Fibrosis Progression in HIV/HCV Coinfected People

Earlier initiation of antiretroviral therapy (ART) and spending more time on HIV treatment may help slow liver disease progression in HIV/HCV co-infected patients, according to an Italian study using non-invasive methods presented at the 13th European AIDS Conference (EACS 2011) last week in Belgrade.
HIVandhepatitis.com
20 Oct 11
Cancer

EACS: Incidence of Non-AIDS Malignancies Stabilizes in D:A:D Study, but Prognosis Improves

Occurrence of non-AIDS-defining cancer has remained stable in recent years, according to an analysis of the large D:A:D observational cohort presented at the 13th European AIDS Conference (EACS 2011) last week in Belgrade.
HIVandhepatitis.com
20 Oct 11
Treatment guidelines

New HIV Treatment Guidelines Focus on Comorbid Conditions

The latest guidelines of the European AIDS Clinical Society (EACS), released here at the society's 13th European AIDS Conference, give special emphasis to comorbid conditions that may occur in patients infected with HIV.
Medscape (requires registration)
16 Oct 11
Access to healthcare

Stockouts: A major threat to HIV treatment in Europe

A key theme at this year’s European AIDS Conference, currently being held in Belgrade, Serbia, is access to treatment and diagnostics.
Key Correspondents
14 Oct 11
Access to healthcare

EATG launches Emergency Guidance on ART forced treatment interruptions due to drug unavailability

The European AIDS Treatment Group (EATG) launches the “Emergency guidance on ART forced treatment interruptions due to drug unavailability (forced stock-outs) for people living with HIV and their care providers in Europe and Central Asia”.
EATG press release
13 Oct 11
More editors' picks

About us

Our information is intended to support, rather than replace, consultation with a healthcare professional.

Talk to your doctor or another member of your healthcare team for advice tailored to your situation.

Connect with us

  • Twitter
  • Facebook
  • YouTube
  • Instagram

Links

Show — Links Hide — Links
  • Contact us
  • THT Direct Helpline
  • Subscribe to email bulletins

 

aidsmap (previously known as NAM aidsmap) is now hosted by Terrence Higgins Trust, an HIV charity based in the United Kingdom.

 

Copyright 2025 © Terrence Higgins Trust is a registered charity in England and Wales (reg. no. 288527) Company reg. no. 1778149 and a registered charity in Scotland (reg. no. SC039986). Registered office: 437 & 439 Caledonian Road, London, N7 9BG.

Footer menu

Show — Footer menu Hide — Footer menu
  • Accessibility
  • Compliment, complaint or concern
  • Our information
  • Privacy & cookies
  • Terms of use
  • Terrence Higgins Trust